You can buy or sell OFIX and other stocks, options, ETFs, and crypto commission-free!
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. Read More The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
52 Week High
52 Week Low
Global Spine Biologics Industry Outlook, 2025 with Profiles of Key Players Including DePuy Synthes, Orthofix Medical, Stryker, and Zimmer Biomet
Dublin, Aug. 04, 2020 (GLOBE NEWSWIRE) -- The "Global Spine Biologics Market: Growth, Trends and Forecasts (2020-2025)" report has been added to ResearchAndMark
-$1.08 per share
-$0.59 per share